Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Novel Coronavirus Disease (Covid-19): A Review of Host Cell Signaling Pathways



Mohammadpour H1 ; Ziai A2 ; Sadr M3 ; Rezaei M3 ; Marjani M4 ; Tabarsi P4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Virology Research Center, National Research Institutes of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Tanaffos Published:2020

Abstract

Coronaviruses (CoVs) are the largest group of positive-sense RNA viruses. By increasing our understanding of the interactions between CoVs and the host innate immune system, we can evaluate the development and persistence of inflammation in the lungs and reduce the risk of CoV-induced lung inflammation with a new group of genetic variants. Here, we aim to discuss some recent changes in host cell factors that may be used by CoV to promote the proliferation cycle. We also discuss different host cell signaling pathways that can be considered in the host-pathogen interactions at the molecular level. The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created new challenges for the cultural, economic, and health infrastructures. Therefore, it is important that healthcare systems and physicians recognize a global integrated framework for monitoring the progression of COVID-19 to develop targeted therapies that can potentially save human lives. © 2020 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran.
Other Related Docs
9. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
15. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
16. Photobiomodulation and Antiviral Photodynamic Therapy in Covid-19 Management, Advances in Experimental Medicine and Biology (2021)
30. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
33. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
36. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
39. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
46. Autoimmune Complications of Covid-19, Journal of Medical Virology (2022)